Melanoma patients whose tumors test positive for mutations in the NRAS gene were more likely to benefit from new immunotherapy drugs, according to a new study led by Vanderbilt-Ingram Cancer Center (VICC) investigators.

Vanderbilt and the Waters Centers of Innovation Program are sponsoring a free symposium titled "Integrated 'Omics in Translational Medicine" on March 23. It is open to all scientists interested in the subject.

Vanderbilt's School of Nursing and Peabody College of education and human development fared well in this year's "U.S. News & World Report" rankings.

Vanderbilt University School of Nursing (VUSN) has been awarded a four-year, $2.4 million grant from the National Institutes of Health/National Institute of Dental and Craniofacial Research to establish a valid, clinically useful measurement battery for head and neck lymphedema and fibrosis (LEF).

Two Vanderbilt-Ingram Cancer Center (VICC) leaders have been named to a panel of the Institute of Medicine (IOM) to help shape national policies on the use of biomarkers for targeted cancer therapies.

To get a sense of how big a change it will be when a new medical coding and reporting system goes into effect later this year, consider this: The current system contains more than 14,000 codes for unique medical diagnoses. The new one has more than 68,000.